1. Zhang C*, Li H, Wang Y, Liu W, Zhang Q, Zhang T, Zhang X, Han B, Zhou G*.Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modifications.J Hepatol, 2010; 53(5): 889-95.
2.Zhang C, Li H, Zhou G*, Zhang Q, Zhang T, Li J, Zhang J, Hou J, Liew CT, Yin D. Transcriptional silencing of the TMS1/ASC tumor suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells. J Pathol, 2007, 212(2): 134-142.
3.Zhang, Xiaoying,Li, Hiu Ming,Liu, Zhiyan,Zhou, Gengyin,Zhang, Qinghui,Zhang, Tingguo,Zhang, Jianping,Zhang, Cuijuan*. Loss of heterozygosity and methylation of multiple tumor suppressor genes on chromosome 3 in hepatocellular carcinoma. J Gastroenterol,2013,48(1):132-143.
4. Yao, Shuzhe，Zhang, Jianping , Chen, Haiyan, Sheng, Yan, Zhang, Xiaoying, Liu, Zhiyan, Zhang, Cuijuan*. Diagnostic value ofimmunohistochemical staining of GP73, GPC3, DCP, CD34, CD31, and reticulinstaining in hepatocellular carcinoma. J Histochem Cytochem. 2013, 61(9): 639-648.
5.Cheng Zhang, Yunfgei Peng, Fan Yang, Ruixi Qin, Wenjun Liu,CuijuanZhang*. PCDH8 is Frequently Inactivated by Promoter Hypermethylation in Liver Cancer: Diagnostic and Clinical Significance. Journal of Cancer. 2016, 7(4): 446-452.
6.Sheng, Yan, Wang, Hongtao, Liu, Dongchen, Zhang, Cheng, Deng, Yupeng, Yang, Fan, Zhang, Tingguo*, Zhang, Cuijuan*.Methylation of tumorsuppressor gene CDH13 and SHP1 promoters and their epigenetic regulation by theUHRF1/PRMT5 complex in endometrial carcinoma.Gynecologic Oncology, 2016, 140(1): 145-151.
7.Chen, Haiyan, Zhang, Tingguo, Sheng, Yan, Zhang, Cheng, Peng, Yunfei, Wang, Xiao, Zhang, Cuijuan*. Methylation Profiling of Multiple TumorSuppressor Genes in Hepatocellular Carcinoma and the Epigenetic Mechanism of3OST2 Regulation. Journal of Cancer. 2015, 6(8): 740-749.
8. Chen, Haiyan#,Zhang, Cuijuan#,*, Sheng, Yan, Yao, Shuzhe, Liu, Zhiyan, Zhang, Cheng, Zhang, Tingguo*.Frequent SOCS3 and 3OST2 promoter methylation and their epigenetic regulation in endometrial carcinoma.American Journal of Cancer Research. 2015, 5(1): 180-190.
9.Liang K#, Wang J#, Wang Y, Zhou Z, Ge S, Mei S, Li H, Jing X,Zhang C*.The histologic, immunohistochemical, and genetic features of classical Hodgkin lymphoma and anaplastic large cell lymphoma with aberrant T-cell/B-cell antigen expression.Hum Pathol. 2019,84:309-320.
10.Zhang C, Ge S, Wang J, Jing X, Li H, Mei S, Zhang J, Liang K, Xu H, Zhang X,Zhang C*.Epigenomic profiling of DNA methylation for hepatocellular carcinoma diagnosis and prognosis prediction. J Gastroenterol Hepatol.2019,34(10):1869-1877.
11.Xu H, Duan N, Wang Y, Sun N, Ge S, Li H, Jing X, Liang K, Zhang X, Liu L, Xue C,Zhang C*. The clinicopathological and genetic features of ovarian diffuse large B-cell lymphoma. Pathology. 2020;52(2):206-212.
12. Wang J, Xu H, Ge S, Xue C, Li H, Jing X, Liang K, Zhang X,Zhang C*.EHMT2 (G9a) activation in mantle cell lymphoma and its associated DNA methylation and gene expression. Cancer Biol Med. 2021;19(6):836-49.
13.Yawei Feng, Shiguan Wang, Jianjun Xie, Bin Ding, Min Wang, Peng Zhang, Ping Mi, Chunxue Wang, Ruirui Liu, Tingguo Zhang, Xiaojing Yu, Detian Yuan,Cuijuan Zhang*.Spatial transcriptomics reveals heterogeneity of macrophages in the tumor microenvironment of granulomatous slack skin.J Pathol.2023;261(1):105-119.
14.Zhang X, Liang K, Chen H, Liu L, Liu R, Wang C,Zhang C*.Genomic analysis reveals molecular characterization of CD30+ and CD30- extranodal natural killer/T-cell lymphomas (ENKTLs).Hum Pathol. 2024 Aug 24;152:105650.
